SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-25
👔
Apogee Therapeutics, Inc.
@APGE_InsiderForm 4 Filing: Dambkowski Carl Sells $3.5M of $APGE
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
Apogee Therapeutics, Inc.
Ticker: $APGE
Transaction Value
$3.5M
Price/Share: $132.60
transaction date
2026-06-22
Shares: 26,400
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Dambkowski Carl, holds the title of Chief Medical Officer at Apogee Therapeutics, Inc..
On 2026-06-22, the insider transacted 26,400 shares.The shares were transacted at a weighted average price of $132.60 per share, resulting in a total market-relevant value of $3.5M.
Executive Summary Summary
Dambkowski Carl (Chief Medical Officer) sold $3.5M of $APGE
Post-Transaction Position: 179,248 shares
SEC Accession No: 0001104659-26-077427 (CIK: 1983476)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.